Sep 2026
Abstract B011: HMGA2 controls fibroblast skewing and immune infiltration in basal pancreatic cancer
The role of tumoral HMGA2 expression in controlling an immunosuppressive TME is demonstrated, a potential biomarker to determine TME phenotype in PDAC patients is highlighted and a novel subtype-specific immunomodulatory therapy is introduced.
Naomi Yamamoto, S. Dobersch, Tess M. Robertson et al.
· Cancer Research · 0 citations